Discover
ICUI
ICU Medical, Inc.
148.46
2 x 107.97
2 x 191.50
bid
ask
+
1.86
1.27%
2 @ 04:00 PM
148.46 +0.00 (0.00%)
| Ytd | 4.06% | |
| 1y | 10.01% |
146.47
day range
152.25
107.00
52 week range
160.29
| Open | 147.61 | Prev Close | 146.60 | Low | 146.47 | High | 152.25 | Mkt Cap | 3.71B |
| Vol | 233.91K | Avg Vol | 296.41K | EPS | 1.85 | P/E | 80.25 | Forward P/E | 15.76 |
| Beta | 0.78 | Short Ratio | 5.97 | Inst. Own | 113.69% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 131.89 | 200-d Avg | 135.46 | 1yr Est | 172.50 |
| Income Statement | |||
| Total Revenue | 530.23M | ||
| Revenues (USD) | 530.23M | ||
| Cost of Revenue | 324.00M | ||
| Gross Profit | 206.23M | ||
| Operating Expenses | 192.65M | ||
| Research and Development Expense | 21.28M | ||
| Selling, General and Administrative Expense | 154.57M | ||
| Operating Income | 13.58M | ||
| Interest Expense | 16.49M | ||
| Income Tax Expense | -34.71M | ||
| Net Income | 30.13M | ||
| Net Income Common Stock | 30.13M | ||
| Net Income Common Stock (USD) | 30.13M | ||
| Consolidated Income | 30.13M | ||
| Earnings per Basic Share | 1.22 | ||
| Earnings per Basic Share (USD) | 1.22 | ||
| Earnings per Diluted Share | 1.20 | ||
| Earning Before Interest & Taxes (EBIT) | 11.91M | ||
| Earning Before Interest & Taxes (USD) | 11.91M | ||
| Weighted Average Shares | 24.76M | ||
| Weighted Average Shares Diluted | 25.18M | ||
| Balance Sheet | |||
| Cash and Equivalents | 288.33M | ||
| Cash and Equivalents (USD) | 288.33M | ||
| Investments | 130.92M | ||
| Investments Non-Current | 130.92M | ||
| Trade and Non-Trade Receivables | 201.08M | ||
| Current Assets | 1.21B | ||
| Property, Plant & Equipment Net | 495.93M | ||
| Total Assets | 4.01B | ||
| Debt Current | 18.75M | ||
| Total Debt | 1.28B | ||
| Current Liabilities | 517.90M | ||
| Debt Non-Current | 1.26B | ||
| Total Liabilities | 1.90B | ||
| Accumulated Retained Earnings (Deficit) | 721.02M | ||
| Accumulated Other Comprehensive Income | -51.90M | ||
| Shareholders Equity | 2.11B | ||
| Shareholders Equity (USD) | 2.11B | ||
| Assets Non-Current | 2.80B | ||
| Total Debt (USD) | 1.28B | ||
| Goodwill and Intangible Assets | 2.08B | ||
| Inventory | 605.59M | ||
| Liabilities Non-Current | 1.38B | ||
| Trade and Non-Trade Payables | 173.98M | ||
| Tax Assets | 25.65M | ||
| Tax Liabilities | 50.37M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 54.20M | ||
| Net Cash Flow from Financing | -44.12M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -19.63M | ||
| Capital Expenditure | -13.21M | ||
| Net Cash Flow - Business Acquisitions and Disposals | 2.00M | ||
| Issuance (Repayment) of Debt Securities | -5.35M | ||
| Net Cash Flow from Investing | -11.21M | ||
| Net Cash Flow from Operations | 38.91M | ||
| Effect of Exchange Rate Changes on Cash | -3.21M | ||
| Share Based Compensation | 14.01M | ||